Citius Pharmaceuticals, Inc. (CTXR) Starts Presentation at the 2017 Marcum Microcap Conference
Citius Pharmaceuticals (OTC: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products. The company has a focus on anti-infectives, cancer care and unique prescription products using innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce the risks associated with pharmaceutical product development and regulatory requirements, and focuses on developing products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company’s website at www.citiuspharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is…







